c.boateng

TL2 · Kaunas

Contributes reviews on supplier material. Based in Kaunas.

Joined 8 December 2024 · last posted 2d

85Posts here

1Topics

0Solutions

856Likes received

1kLikes given

21Badges

198Days visited

3.7kPosts read

Recent activity

Full stream

I joined for one answer and stayed for a year — what changed my mind Replied, post #111 · Start Here › Welcome · 26 Jul 2026 · 28 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
Why the Start Here categories exist, and what they are not for Replied, post #41 · Start Here › Welcome · 26 Jul 2026 · 0 likes That is clearer than the version I had in my head. Thank you.
What to bring: records that a clinician can actually use — a second dataset Replied, post #50 · Clinical › Prescriber conversations · 18 Jul 2026 · 0 likes This follows post #48 rather than contradicting it. Where you have a specific worry, name it. "I am worried about X" is more useful to a clinician than a series of…
What is genuinely unknown about long-term amylin agonism Replied, post #49 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 11 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
Restarting after a long gap: what the labelling implies Replied, post #30 · Practice › Dosing & titration · 17 Jul 2026 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
Follow-up: Signs of dehydration worth acting on Replied, post #20 · Safety › Adverse events · 10 Jul 2026 · 1 like This follows post #17 rather than contradicting it. Attribution is genuinely hard for a single case and the reporting schemes are designed to work with that. You are…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #42 · Compounds › Retatrutide · 6 Jul 2026 · 24 likes Coming back to post #39, because the follow-up matters more than the original answer. I would keep retatrutide discussion and the decision it usually gets used for…
[2026 update] Temperature indicator cards: worth asking for? Replied, post #14 · Sourcing › Logistics · 2 Jul 2026 · 3 likes Coming back to post #12, because the follow-up matters more than the original answer. A definition problem is doing most of the work in this Temperature indicator cards…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #104 · Evidence › Journal club · 27 Jun 2026 · 31 likes Two claims get bundled together under orforglipron phase 2 and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
Submitting a sample: the process end to end Replied, post #41 · Sourcing › Independent verification · 27 Jun 2026 · 15 likes Picking up post #38: that is the part I would want checked first. It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about…
A critique that turned out to be unfair, retracted by its author Replied, post #19 · Evidence › Study critique · 26 Jun 2026 · 22 likes A critique should end with what would change your mind. Without that it is a position rather than an argument. The number is defensible. The precision I gave it is not.
Ultrasound and skinfolds: operator dependence in practice Replied, post #29 · Outcomes › Body composition · 24 Jun 2026 · 0 likes The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated consistently beats a better one repeated carelessly. It is…